[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

Crinetics Pharmaceuticals, Inc. (CRNX)

Crinetics Pharmaceuticals ($CRNX) is presenting new data on Paltusotine at ENDO 2025, but negative sentiment persists due to financial concerns and market cap decline.

About Crinetics Pharmaceuticals, Inc.

Crinetics Pharmaceuticals, Inc. (CRNX) is a biopharmaceutical company focused on novel therapeutics for endocrine diseases and tumors.
Crinetics Pharmaceuticals, Inc. uses the ticker $CRNX for trading. Listed in the Stocks and category within the Healthcare sectors.

Insights #

Crinetics Pharmaceuticals, Inc. (CRNX) social dominance is up XXXXX% from the previous week.
Crinetics Pharmaceuticals, Inc. (CRNX) galaxy score™ is up XXXXX% from the previous week.
Crinetics Pharmaceuticals, Inc. (CRNX) sentiment is up XXXXX% from the previous week.

Price: $XXXXX #

Price 24-Hour Chart Data
The stock price decline is likely due to a combination of financial losses, market cap decrease, and negative sentiment despite strong cash position and upcoming clinical data, as reflected in the 24-hour price change of -2.54%.

24-Hour	7-Day	30-Day
-XXXX%	-XXXX%	XXXX%

1-Year High: $XXXXX on 2024-11-08
1-Year Low: $XXXXX on 2025-04-08

AltRank: XXXXX #

AltRank Line Chart
AltRank 24-Hour Chart Data
Crinetics Pharmaceuticals, Inc. (CRNX) is currently AltRank #1,934 based on combined combined social and market metrics Daily Average: XXX
1 Week: XXXXX +1,390
1 Month: XXXXX +235
6 Months: XXXXX +1,070
1 Year: XXXXX +1,687
1-Year High: XXXXX on 2025-06-30
1-Year Low: XX on 2024-10-05

Galaxy Score: XXXXX #

Galaxy Score Line Chart
Galaxy Score 24-Hour Chart Data
Current Value: XXXXX
Daily Average: XX
1 Week: XX +14
1 Month: XX +2
6 Months: XX -X
1 Year: XX +34
1-Year High: XX on 2024-08-08
1-Year Low: XX on 2025-06-21

Engagements: XXXXX #

Engagements Line Chart
Engagements 24-Hour Chart Data
Current Value: XXXXX
Daily Average: XXXXX
1 Week: XXXXXX -XX%
1 Month: XXXXXXX +148%
6 Months: XXXXXXX -XX%
1 Year: XXXXXXXXX -XXXX%
1-Year High: XXXXXX on 2024-10-04
1-Year Low: XXX on 2025-03-30

Social Network	X
Engagements	XXXXX

Mentions: XX #

Mentions Line Chart
Mentions 24-Hour Chart Data
Current Value: XX
Daily Average: XX
1 Week: XXX -XX%
1 Month: XXX +491%
6 Months: XXXXX +5.40%
1 Year: XXXXX +76%
1-Year High: XXX on 2025-01-21
1-Year Low: X on 2024-09-17

Social Network	X
Mentions	XXX

Creators: XX #

Creators Line Chart
Creators 24-Hour Chart Data
XX unique social accounts have posts mentioning Crinetics Pharmaceuticals, Inc. (CRNX) in the last XX hours which is down XX% from XX in the previous XX hours Daily Average: XX
1 Week: XXX -XX%
1 Month: XXX +888%
6 Months: XXX +70%
1 Year: XXXXX +177%
1-Year High: XXX on 2025-06-27
1-Year Low: X on 2024-09-17

The most influential creators that mention Crinetics Pharmaceuticals, Inc. in the last XX hours

Creator	Rank	Followers	Posts	Engagements
@Andre_AGTC	X	XXXXX	X	XXX

Sentiment: XX% #

Sentiment Line Chart
Sentiment 24-Hour Chart Data
Current Value: XX%
Daily Average: XX%
1 Week: XXX% +17%
1 Month: XX% +8%
6 Months: XX% +24%
1 Year: XX% +18%
1-Year High: XXX% on 2024-07-22
1-Year Low: XX% on 2024-09-09

Most Supportive Themes

Paltusotine NDA Approval Anticipation: (20%) Positive anticipation surrounds the PDUFA date for Paltusotine NDA approval.
Strong Cash Position: (5%) Crinetics has a strong cash position, which can provide stability amid financial challenges.

Most Critical Themes

Financial Losses and Market Cap Decline: (60%) Concerns about financial losses, market cap decline, and decreased social engagement are key issues for Crinetics Pharmaceuticals.
Decreased Social Engagement: (10%) Decreased social engagement signals a potential loss of interest or negative sentiment.
Negative Sentiment: (5%) Negative sentiment expressed in recent posts reflects concerns and a bearish outlook on the stock.

Network engagement breakdown:

Network	Positive	%	Neutral	%	Negative	%
X	XXXXX	XX%	XXXXX	XX%	XX	X%

Total	XXXXX	XX%	XXXXX	XX%	XX	X%

Social Dominance: XXXXXXX% #

Social Dominance Line Chart
Social Dominance 24-Hour Chart Data
Current Value: XXXXXXX%
Daily Average: XXXXX%
1 Week: XXXXX% +0.00325%
1 Month: XXXXX% -XXXXX%
6 Months: XXXXX% -XXXXX%
1 Year: XXXXX% -XXXXXX%
1-Year High: XXXXX% on 2025-06-28
1-Year Low: XXXXXX% on 2024-09-17

Market Dominance: XXXXXXX% #

Market Dominance Line Chart
Market Dominance 24-Hour Chart Data
Current Value: XXXXXXX%
Daily Average: X%
1-Year High: XXXXX% on 2024-11-05
1-Year Low: XXXXXXX% on 2025-07-20

Market Cap: $XXXXXXXXXXXXX #

Market Cap Line Chart
Market Cap 24-Hour Chart Data
Current Value: $XXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXX
1 Week: $XXXXXXXXXXXXX -$2.50%
1 Month: $XXXXXXXXXXXXX +$3.20%
6 Months: $XXXXXXXXXXXXX -$19%
1 Year: $XXXXXXXXXXXXX -$30%
1-Year High: $XXXXXXXXXXXXX on 2024-11-08
1-Year Low: $XXXXXXXXXXXXX on 2025-04-08

Top assets mentioned In the posts about Crinetics Pharmaceuticals, Inc. in the last XX hours

Neurocrine Biosciences, Inc. (NBIX) SuperRare (RARE) Bitcoin Incognito (XBI) Regeneron Pharmaceuticals Inc (REGN) Akropolis (AKRO) Vertex Protocol (VRTX) BridgeBio Pharma, Inc. Common Stock (BBIO) Dyne Therapeutics, Inc. Common Stock (DYN) Eli Lilly and Company (LLY)

Top topics mentioned In the posts about Crinetics Pharmaceuticals, Inc. in the last XX hours

stocks, $nbix, $rare, $xbi, $vrna, pfe, $regn, $futu, $akro, investment, $vrtx, $argx, $mirm, cort, telo, aes, $amze, $gpcr, $veon, $fsm, drugs, srm, op, insp, $hik, $vrdn, $wve, $bbio, $dyn, $mreo, $abeo, soc, mira, $tlx, $tak, $mgx, $cvm, vir, $lly, grrr, $tds, $qntm, $lyel, stx, cah, alt, zk, $biib, $nvs, $rgls, $insm, $axsm, $ptix, abbv, novo, qubt, $mdgl, $srpt, $atai, $kzia, atai life, pep, xyz, baba, pltr, amzn, nvda, dtc, $cycn, ys, hum, $ys, $vtyx, monaco, $imcr, $gff, $rna, $intr, $alny, $arqq, $lrmr, $bhvn, $tnxp, manat, $prme, kol, accounting, goldman sachs, $imrx, $cycc, $repl, $stok, $plrx, $ocul, i met, ang, bbdo, $tnk, $autl, $grrr